Leaders in Pharmaceutical Business Intelligence (LPBI) Group

WordCloud Visualization of LPBI’s Top Twelve Articles by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com

Curators: Daniel Menzin, Noam Steiner-Tomer, Zach Day, Ofer Markman, PhD, Aviva Lev-Ari, PhD, RN

 

Article Name Live Link	Views All Time	Categories of Research
#1 Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?	17,140	Biological Networks, CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Disease Biology, Genome Biology, Imaging-based Cancer Patient Management, International Global Work in Pharmaceutical, Liver & Digestive Diseases Research, Metabolomics, Molecular Genetics & Pharmaceutical, Nutrition, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Population Health Management, Proteomics, Stem Cells for Regenerative Medicine, Technology Transfer: Biotech and Pharmaceutical | Tagged Adenosine triphosphate, ATP, Glycolysis, Hypoxia-inducible factors, Kreb, Lactate dehydrogenase, Mammalian target of rapamycin, Mitochondrion, Warburg Effect
#2 Recent comprehensive review on the role of ultrasound in breast cancer management	14,553	Biomarkers & Medical Diagnostics, Health Economics and Outcomes Research, Healthcare costs and reimbursement, Imaging-based Cancer Patient Management, Medical Device Therapies for Altzheimer’s Disease, Medical Devices R&D Investment, Medical Imaging Technology, Image Processing/Computing, MRI, CT, Nuclear Medicine, Ultra Sound | Tagged breast biopsies, breast cancer, breast cancer management, breast cancer screening, breast cyst, breast lesions, breast ultrasound, mammography, MRI, Personalized medicine, PET, support breast cancer, tomosynthesis, yale university school, yale university school of medicine
#3 Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran)	13,893	Coagulation Therapy and Internal Bleeding, Electrophysiology, FDA Regulatory Affairs, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease | Tagged Academic Medical Center, Amsterdam, Anticoagulant, Apixaban, Dabigatran, Direct thrombin inhibitor, Direct Xa inhibitor, Food and Drug Administration, New England Journal of Medicine, Non-steroidal anti-inflammatory drug, Northeastern University, PRADAXA, Prothrombin time, Rivaroxaban, VTE, Warfarin
#4 Paclitaxel vs Abraxane (albumin-bound paclitaxel)cent comprehensive review on the role of ultrasound in breast cancer management	13,878	BioSimilars, CANCER BIOLOGY & Innovations in Cancer Therapy, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Nanotechnology for Drug Delivery, Pharmaceutical Analytics, Pharmaceutical R&D Investment, Regulated Clinical Trials: Design, Methods, Components and IRB related issues | Tagged Abraxane, albumin-bound paclitaxel, breast cancer, clinical studies, FREE paclitaxel, linear PK, non-linear PK, Paclitaxel, Pharmacokinetics, PK, side effects, Taxol
#5 Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications	8,367	Coagulation Therapy and Internal Bleeding, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease, tagged Dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
#6 Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care	8,068	Medical Devices R&D Investment, Nitric Oxide in Health and Disease, Technology Transfer: Biotech and Pharmaceutical | Tagged ARDS, Aviva Lev-Ari, Inhaled Nitric Oxide, nitric oxide, prostacyclin, Pulmonary hypertension, Respiratory failure
#7 Our Team	6,553	LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management
#8 Mesothelin: An early detection biomarker for cancer (By Jack Andraka)	6,545	Advanced Drug Manufacturing Technology, Bio Instrumentation in Experimental Life Sciences Research, Biological Networks, Gene Regulation and Evolution, Biomarkers & Medical Diagnostics, BioSimilars, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Prevention: Research & Programs, Cell Biology, Signaling & Cell Circuits, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Health Economics and Outcomes Research, Medical Devices R&D Investment, Nanotechnology for Drug Delivery, Pharmaceutical R&D Investment, Population Health Management, Genetics & Pharmaceutical, Regulated Clinical Trials: Design, Methods, Components and IRB related issues, Technology Transfer: Biotech and Pharmaceutical | Tagged Blood test, carbon nanotubes, early detection, Mesothelin, Pancreatic cancer
#9 Biochemistry of the Coagulation Cascade and Platelet Aggregation: Nitric Oxide: Platelets, Circulatory Disorders, and Coagulation Effects	5,235	Aortic Valve: TAVR, TAVI vs Open Heart Surgery, Biomarkers & Medical Diagnostics, Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Coagulation Therapy and Internal Bleeding, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Metabolomics, Mitral Valve: Repair and Replacement, Nitric Oxide in Health and Disease, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Industry Competitive Intelligence, Pharmacotherapy of Cardiovascular Disease, Population Health Management, Nutrition and Phytochemistry, Proteomics | Tagged anti-inflammatory, anti-TNF, Anticoagulant, Antithrombin, blood flow resistance, cell junctions, cellular adhesion, Coumadin, Endothelial cells, Factor IX and IXa, Factor VII and VIIa, Factor VIII and Factor VIIIa, Factor X and Xa, fibrinogen, fibrinolysis, heparin, Hypoxia-inducible factors, Non-steroidal anti-inflammatory drug, Partial thromboplastin time, Physiology, plasmin, platelet aggregation, platelets, prothrombin, soluble fibrin, subendothelial matrix, Thrombin, thrombomodulin, Thrombus, tissue factor, TNF-a, Von Willebrand factor, WH Seegers
#10 Interaction of enzymes and hormones	5,173	Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Metabolomics, Population Health Management, Genetics & Pharmaceutical, Population Health Management, Nutrition and Phytochemistry, Reproductive Andrology, Embryology, Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics | Tagged active compounds, enzyme, hormone, interaction, Metabolism, Therapy
#11 Akt inhibition for cancer treatment, where do we stand today?	4,865	CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Signaling & Cell Circuits | Tagged Cancer research, cancer therapy, Cell Biology, mTOR, NF-κB, PI3K/AKT pathway, PTEN, Signal transduction
#12 The History and Creators of Total Parenteral Nutrition	4,660	Disease Biology, Gastroenterology, Uncategorized | Tagged Amino acids, enteral nutrition, Nutrition, TPN

#1

Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?

Article #1: WordCloud by DM

#2

Recent comprehensive review on the role of ultrasound in breast cancer management

Article #2: WordCloud by NT

#3

Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran)

Article #3: WordCloud by ZD

#4

Paclitaxel vs Abraxane (albumin-bound paclitaxel)cent comprehensive review on the role of ultrasound in breast cancer management

Article #4: WordCloud by DM

#5

Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications

Article #5: WordCloud by ZD

#6

Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care

Article #6: WordCloud by NT

#7

Our Team

Article #7: WordCloud by DM

#8
Mesothelin: An early detection biomarker for cancer (By Jack Andraka)

Article #8: WordCloud by NT

#9

Biochemistry of the Coagulation Cascade and Platelet Aggregation: Nitric Oxide: Platelets, Circulatory Disorders, and Coagulation Effects

Article #9: WordCloud by NT

#10

Interaction of enzymes and hormones

Article #10: WordCloud by ZD

#11

Akt inhibition for cancer treatment, where do we stand today?

Article #11: WordCloud by DM

#12

The History and Creators of Total Parenteral Nutrition

Article #12: WordCloud by DM

Share this:

• Tweet
• Print
• Email
• More

Like this:

Like Loading...

Posted in Academic Publishing, LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management | 2 Comments

2 Responses

1. on July 23, 2020 at 11:12 AM | Reply sjwilliamspa

   So my suggestion would be actually to focus on the little words, which will give more insight into future targets, as the large words are well known. For example AKT, PI3K cancer is very well studied and dominates the literature. However, looking at some of the lesser ones, siRNA, targeting ,nuclear, complex, breast, targeted can one form into logical sentences which describe new avenues for research?

   Loading...

   
   
2. on November 16, 2020 at 4:41 PM | Reply Data Architecture for Blockchain Deployment of Digital Assets: LPBI IP Asset Classes I,II,III | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

   […] WordCloud Visualization of LPBI’s Top Twelve Articles by Views at All Time and their Research … […]

   Loading...